Guangxi Wehand-Bio Pharmaceutical

Guangxi Wehand-Bio Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical enterprise headquartered in Guilin, specializing in the research, development, and manufacturing of active pharmaceutical ingredients (APIs) and high-end intermediates. The company is a leading global supplier of antimalarial treatments, with a core focus on artemisinin and its derivatives, including artesunate, artemether, and dihydroartemisinin. Operating under strict international GMP standards, Wehand-Bio provides high-quality chemical products to pharmaceutical companies and health organizations worldwide. Their expertise extends to complex chemical synthesis and natural product extraction, supporting a diverse portfolio of therapeutic applications. The company plays a critical role in the global supply chain for essential medicines, particularly in the fight against malaria in developing regions.